Optimization of proper diagnosis of thromboses associated with high risk of embolism in patients with neoplasms

Abstract

Aim. To optimize a proper diagnosis of thromboses associated with high risk of embolism and pulmonary embolism prevention in patients with neoplasms. Methods. Ultrasonography of veins of lower extremities, iliac veins and the distal part of inferior vena cava was performed in patients with and without neoplasms in a prospective study to detect thromboses associated with high risk of embolism and thrombophlebitis. Ultrasonography was performed once in control group subjects, and before and during specialized antineoplastic treatment (surgical, chemotherapy, radiotherapy) in patients of the main group, the results were compared. A detection of a new thrombus in previously intact venous segment of inferior vena cava system was assessed as a high risk for pulmonary embolism. Results. Thromboses associated with high risk of embolism and thrombophlebitis were found in 6 patients of control group, in 5 patients of the main group before and in 27 patients of the main group while at specialized antineoplastic treatment. Specific measures for pulmonary embolism prevention were taken immediately in all of the cases according to ultrasonography results after the detection of thromboses associated with high risk of embolism. No fatal cases of pulmonary embolism were registered both in main (before and while at treatment) and control groups. Conclusion. Ultrasonography of veins of lower extremities, iliac veins and the distal part of inferior vena cava in patients with neoplasms before the start of specialized antineoplastic treatment allows to optimize the choice of prevention measures for pulmonary embolism and thus significantly decreases mortality from pulmonary embolism.

Keywords

neoplasms / tumors / pulmonary embolism / targeted prevention

References

[1] Савельев В.С., Чазов Е.И., Гусев Е.И. и др. Российские клинические рекомендации по диагностике, лечению и профилактике венозных тромбоэмболических осложнений // Флебология. - 2010. - №1. - C. 1-37.

[2] Blom J.W., Doggen C.J., Osanto S. et al. Malignancies, prothrombotic mutations, and the risk of venous thrombosis // JAMA. - 2005. - Vol. 293. - P. 715-722.

[3] Chew H.K., Wun T., Harvey D. et al. Incidence of venous thromboembolism and its effect on survival among patients with common cancers // Arch. Intern. Med. - 2006. - Vol. 166. - P. 458-464.

[4] Gallus A.S. Prevention of post-operative deep leg vein thrombosis in patients with cancer // Thromb. Haemost. - 1997. - Vol. 78. - P. 126-132.

[5] Heit J.A., Silverstein M.D., Mohr D.N. et al. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study // Arch. Intern. Med. - 2000. - Vol. 160. - P. 809-815.

[6] Kroger K., Weiland D., Ose C. et al. Risk factors for venous thromboembolic events in cancer patients // Ann. Oncol. - 2006. - Vol. 17. - P. 297-303.

[7] Lyman H.G., Khorana A.A., Falanga A. et al. American Society of Clinical Oncology Guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer // J. Clin. Oncol. - 2007. - Vol. 25, N 34. - P. 5490-5505.

[8] Prandoni P., Lensing A.W., Piccioli A. et al. Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis // Blood. - 2002. - Vol. 100. - P. 3484-3488.

[9] Silverstein M.D., Heit J.A., Mohr D.N. et al. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study // Arch. Intern. Med. - 1998. - Vol. 158. - P. 585-593.

[10] Sorensen H.T., Mellemkjaer L., Olsen J.H. et al. Prognosis of cancers associated with venous thromboembolism // N. Engl. J. Med. - 2000. - Vol. 343. - P. 1846-1850.

RIGHTS & PERMISSIONS

Kamalov I.A., Agliullin I.R., Tukhbatullin M.G.